USPTO serial 79363090
Reviewed by CopyMark Law Group
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Food for diabetics; anti-diabetic pharmaceuticals; anti-diabetic preparations; sugar substitutes for diabetics; bread products for diabetics; pharmaceutical preparations for treating diabetes; artificial sweeteners adapted for diabetics; diabetic bread adapted for medical use; foodstuffs for diabetics [specially made for]; chemical preparations for the diagnosis of diabetes; pharmaceutical preparations for the prevention of diabetes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for the prevention of disorders of the metabolic system; dietetic and nutritional preparations and supplements | ACTIVE | — |
| 035 | Hospital management; administrative management of hospitals; medical billing services for hospitals; business management of hospitals; development of hospital management systems; administrative services relating to hospital referrals | ACTIVE | — |
| 041 | Medical education services; educational and training services relating to healthcare; educational and training services relating to obesity, diabetes and/or other metabolic disorders for the public, healthcare professionals and patients; conducting educational support programmes for the public, healthcare professionals and patients in relation to obesity, diabetes and/or other metabolic disorders | ACTIVE | — |
| 044 | Hospitals; hospital services; medical consultations; medical screening; medical nursing; medical examinations; medical assistance; medical healthcare and pharmaceutical services; healthcare consultancy and advisory services; medical and healthcare clinics; medical services in the field of obesity, diabetes and other metabolic disorders; medical screening services; analysis of human tissues and metabolites for medical treatment; provision of information in the fields of obesity, diabetes and other metabolic disorders; medical treatment and analysis services and related medical advice in the field of obesity, diabetes and other metabolic disorders; medical treatment services; diabetes screening services; professional consultancy relating to health care and the treatment and prevention of diabetes, obesity and metabolic disorders; medical information; providing medical information in the field of diabetes, obesity and metabolic disorders; providing information to patients and the public relating to metabolic illnesses; providing medical information in the field of weight loss; providing nutritional information about food and drink for medical weight loss purposes; weight reduction diet planning and supervision; consultation services in the field of weight management; dietary and nutritional advice; providing information to patients relating to the administration of medications; preparation of prescriptions to patients; medical counselling; monitoring patients and counselling services for patients considering bariatric surgery; analysis and treatment services for patients with obesity, diabetes and/or other metabolic disorders; bariatric surgery | ACTIVE | — |
| 045 | Providing patient advocate services to hospital, health clinic and medical centre patients | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 31, 2025 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 14, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 14, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 13, 2024 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 13, 2024 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 13, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 13, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 23, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 23, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 11, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 10, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 25, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 21, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 16, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |